Genus plc (LON:GNS)

Market Cap	1.79B +50.9%
Revenue (ttm)	672.00M +0.1%
Net Income	47.50M
EPS	0.71
Shares Out	66.91M
PE Ratio	37.69
Forward PE	25.78
Dividend	0.32 (1.20%)
Ex-Dividend Date	Mar 5, 2026

Volume	146,629
Average Volume	179,000
Open	2,615.00
Previous Close	2,670.00
Day's Range	2,570.00 - 2,670.00
52-Week Range	1,548.00 - 3,228.80
Beta	0.85
RSI	31.13
Earnings Date	Feb 26, 2026

About Genus

Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1994
• Employees: 3,190
• Stock Exchange: London Stock Exchange
• Ticker Symbol: GNS

Financial Performance

In fiscal year 2025, Genus's revenue was 672.80 million, an increase of 0.60% compared to the previous year's 668.80 million. Earnings were 19.30 million, an increase of 144.30%.